Showing results (41-50 of 194) with videos related to
Sort By:
Pageof 20
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1981
Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergyC J Hawkey, J Newsom-Davis, A VincentProceedings of the Royal Society of London. Series B, Biological Sciences|October 22, 1988
The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricleB Lang, J Newsom-Davis, D W WrayNeurology|May 1, 1986
Myasthenia gravis: monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatmentP J Whiting, A Vincent, J Newsom-DavisJournal of Neuroimmunology|August 1, 1983
Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclassP J Whiting, A Vincent, J Newsom-DavisJournal of Neurology, Neurosurgery, and Psychiatry|December 1, 1991
3,4-Diaminopyridine in the treatment of congenital (hereditary) myastheniaJ Palace, C M Wiles, J Newsom-DavisMuscle & Nerve|August 14, 1998
Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert-Eaton myasthenic syndromeP Maddison, J Newsom-Davis, K R MillsNeurology|November 14, 2001
Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?C Buckley, J Newsom-Davis, N Willcox, et al.Eye (London, England)|January 1, 1990
Ocular autonomic nerve function in Lambert-Eaton myasthenic syndromeC V Clark, J Newsom-Davis, M D SandersThe Journal of Physiology|November 1, 1983
Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouseB Lang, J Newsom-Davis, C Prior, et al.Autoimmunity|January 1, 1992
Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodiesA Roberts, B Lang, A Vincent, et al.Pageof 20